GIn192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 14
- DOI:
- No doi available
- Key Word:
- Alzheimer disease;paraoxonase 1;gene;single nucleotide polymorphism
Abstract： Background Oxidative stress such as low-density lipoprotein (LDL) oxidation is thought to be an important mechanism in Alzheimer's disease (AD). Paraoxonase 1 (PON1), an enzyme located on high-density lipoprotein,can prevent LDL from oxidation to some extent. It is also a potent cholinesterase inhibitor and an arylesterase,combating organophosphate poisoning and metabolization of environmental neurotoxins which might be responsible for neurodegeneration with aging. We evaluated the association of Gln192Arg polymorphism in the PON1 gene with AD in a Chinese Han ethnic population.Methods Patients and age-matched controls were recruited from outpatient clinics and a population-based epidemiological survey, respectively. Gln192Arg polymorphism in the PON1 gene was detected by allele-specific PCR technique in 521 patients with AD and 578 healthy controls.Results The presence of at least one of PON1 R alleles (Q/R or R/R) was lower in AD patients than in the controls (82.7% vs 87.4%; x2 = 4.68, P = 0.03). PON1 gene R allele frequency was lower in AD patients than in the controls (60.7% vs 64.7%, X2=3.85, P = 0.05). One-way ANOVA showed that PON1 genotype had no effect on the age of onset for developing AD. Logistic regression analysis demonstrated the age and sex-adjusted odds ratio (OR) for the risk of AD in PON1 of PON1 R allele carriers was 0.71 (P = 0.044, 95%CI, 0.51 - 0.99).Conclusion Our results indicate that Gln192Arg polymorphism in the PON1 gene is associated with AD, and PON1 R allele might be a protective factor for AD in a Chinese Han ethnic population.
- [1]A D, Roses.Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases.[J].1998,81(1).
- [2]Furlong CE,Richter RJ.Determination of paraoxonase (PON1) status requires more than genotyping.[J].1999,9(6).
- [3]H G, Davies,R J, Richter,M, Keifer,etc.The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.[J].1996,14.
- [4]S, Germer,M J, Holland,R, Higuchi.High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.[J].2000,10(2).
- [5]Sodeyama N,Matsushita M,Otomo E,etc.No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease.[J].1999,53(5).
- [6]Dominique Campion,Cécile Dumanchin,Didier Hannequin,etc.Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum[J].1999,65(3).
- [7]Michael I. Mackness,Sharon Arrol,Caroline Abbott,etc.Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase[J].1993,104(1-2).
- [8]Beisiegel U,Arlt S,Kontush A.Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease.[J].2002,13(3).
- [9]Broggio E,Corbo RM,Scacchi R,etc.Different pattern of association of paraoxonase Gln192-->Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease.[J].2003,339(1).
- [10]Y M, Kuo,M R, Emmerling,C L, Bisgaier,etc.Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.[J].1998,252.
- [11]Kondo, I.,Yamamoto, M..Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease[J].1998,806(2).
- [12]Cole TB,Vitalone A,Furlong CE,etc.Modulation of paraoxonase (PON1) activity.[J].2005,69(4).
- [13]C.E. Furlong,L.G. Costa,C. Hassett,etc.Human and rabbit paraoxonases: Purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification[J].1993,87(1-3).
- [14]S L, Primo-Parmo,R C, Sorenson,J, Teiber,etc.The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.[J].1996,33(3).
- [15]R, Humbert,D A, Adler,C M, Disteche,etc.The molecular basis of the human serum paraoxonase activity polymorphism.[J].1993,3.
- [16]Cascorbi I,Roots I,Baumann G,etc.Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery disease.[J].1999,9(6).
- [17]Woltjer RL,Maeda N,Montine KS,etc.Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity.[J].2004,91(6).
- [18]Roberto, Pola,Eleonora, Gaetani,Andrea, Flex,etc.Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population.[J].2003,15.
- [19]Seres I,Balla P,Egerhazi A,etc.Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.[J].2002,252(2).